Epigenomics AG / Key word(s): Strategic Company Decision/Change in ForecastEpigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance 17-Aug-2021 / 21:00 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for […]
Category: Insider Information
17. August 2021
Epigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance
11. June 2021
Epigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million
Epigenomics AG / Key word(s): Bond/FinancingEpigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million 11-Jun-2021 / 21:05 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible […]
18. May 2021
Epigenomics AG successfully completes capital increase
Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG successfully completes capital increase 18-May-2021 / 08:51 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. NOT FOR PUBLICATION, DISTRIBUTION […]
27. April 2021
Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders
Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders 27-Apr-2021 / 17:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible […]
25. March 2021
Epigenomics AG is Evaluating M&A Options
Epigenomics AG / Key word(s): Strategic Company DecisionEpigenomics AG is Evaluating M&A Options 25-March-2021 / 10:48 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. NOT TO BE […]
27. January 2021
Epigenomics AG successfully places mandatory convertible bond in the full amount of EUR 5.5 million
Epigenomics AG / Key word(s): Bond/Issue of DebtEpigenomics AG successfully places mandatory convertible bond in the full amount of EUR 5.5 million 27-Jan-2021 / 20:11 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible […]